JMVZX | JVMCX | JMVZX / JVMCX | |
Total Expense Ratio | 1.35 | 1.87 | 72% |
Annual Report Gross Expense Ratio | 1.46 | 1.88 | 78% |
Fund Existence | 17 years | 14 years | - |
Gain YTD | -0.986 | 3.241 | -30% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.4B | 21.7B | 57% |
Annual Yield % from dividends | 0.50 | 0.00 | - |
Returns for 1 year | -3.52 | -3.33 | 106% |
Returns for 3 years | -1.40 | 14.63 | -10% |
Returns for 5 years | 10.41 | 47.10 | 22% |
Returns for 10 years | -7.95 | 26.63 | -30% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
AAAU | 33.91 | 0.44 | +1.33% |
Goldman Sachs Physical Gold ETF | |||
FCFY | 24.28 | N/A | N/A |
First Trust S&P 500 Div Fr CA Flw ETF | |||
MPA | 10.68 | -0.07 | -0.69% |
Blackrock Muniyield Pennsylvania Quality Fund | |||
NUMG | 46.71 | -0.65 | -1.38% |
Nuveen ESG Mid-Cap Growth ETF | |||
GNOM | 8.30 | -0.13 | -1.51% |
Global X Genomics & Biotechnology ETF |